New cancer clinical trial: Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Solid Tumours

Published on: July 25, 2018 at 12:00PM
Conditions:   Solid Tumor;   Androgen Receptor Gene Overexpression
Intervention:   Drug: SEVI-D (Seviteronel in combination with dexamthasone)
Sponsor:   St Vincent's Hospital, Sydney
Not yet recruiting
https://ift.tt/2mS0n1H